Correction to: Betulinic acid inhibits endotoxin-stimulated phosphorylation cascade and pro-inflammatory prostaglandin E2 production in human peripheral blood mononuclear cells: Betulinic acid inhibits LPS-induced inflammation (British Journal of Pharmacology, (2011), 162, 6, (1291-1303), 10.1111/j.1476-5381.2010.01112.x);Betulinic acid inhibits endotoxin-stimulated phosphorylation cascade and pro-inflammatory prostaglandin E2 production in human peripheral blood mononuclear cells

British Journal of Pharmacology

Volumn 162, Issue 6, 2011, Pages 1291-1303

  Viji, Vijayan ^a   Helen, Antony ^a   Luxmi, Varma R ^b  

^a UNIVERSITY OF KERALA   (India)

^b REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

Akt; betulinic acid; cyclooxygenase; ERK; inflammatory mediators; I B ; lipopolysaccharide; mononuclear cell; NF B

Indexed keywords

BETULIC ACID; CYCLOOXYGENASE 2; ENDOTOXIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; PROSTAGLANDIN E2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 79951984775     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.15519     Document Type: Erratum

References (52)

1. Ajizian SJ, English BK, Meals EA, (1999). Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and inte (Pubitemid 29159340)
2. Balkwill F, Mantovani A, (2001). Inflammation and cancer: back to Virchow? Lancet 357: 539-545. (Pubitemid 32173595)
3. Barnes PJ, Karin M, (1997). Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071. (Pubitemid 27163860)
4. Baud V, Karin M, (2009). Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 8: 33-40.
5. Bellacosa A, Testa JR, Staal SP, Tsichlis PN, (1991). A retroviral oncogene, Akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277. (Pubitemid 21917339)
6. Beraud C, Henzel WJ, Baeuerle PA, (1999). Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc Natl Acad Sci USA 96: 429-434. (Pubitemid 29061225)
7. Bradley PP, Priebat DA, Christensen RD, Rothstein G, (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209. (Pubitemid 12171880)
8. Chatterji N, Rastogi RP, Dhar ML, (1963). Chemical examination of Bacopa monniera Wettst: part I-isolation of chemical constituents. Indian J Chem 1: 212-217.
9. 450 activity in rat brain. Phytother Res 16: 639-645. (Pubitemid 35334184)
10. Chowdhury AR, Mandal S, Mittra B, Sharma S, Mukhopadhyay S, Majumder HK, (2002). Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med Sci Monit 8: 254-265.
11. Cnubben NHP, Rietjens IMCM, Wortelboer H, Van-Zanden J, Van Bladeren PJ, (2001). The interplay of glutathione related processes in antioxidant defense. Environ Toxicol Pharmacol 10: 141-152. (Pubitemid 32831507)
12. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761. (Pubitemid 40385531)
13. Germain M, Gagnon V, Parent S, Asselin E, (2004). Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-κB/IκB pathway. Mol Cancer 3: 17-26.
14. Gorgoni B, Caivano M, Arizmendi C, Poli V, (2001). The transcription factor C/EBPβ is essential for inducible expression of the COX-2 gene in macrophages but not in fibroblasts. J Biol Chem 276: 40769-40777.
15. Haque ME, Shekhar HU, Mohamad AU, Rahman H, Islam AMI, Hossain MS, (2006). Triterpenoids from the stem bark of Avicennia officinalis. Dhaka Univ J Pharm Sci 5: 53-57.
16. Huch HY, Pearce SF, Tersner JM, Schindler IL, Silverstein RL, (1996). Regulated expression of CD36 in foam cell formation. Blood 87: 2020-2025.
17. Janssen-Heininger YM, Poynter ME, Baeuerle PA, (2000). Recent advances towards understanding redox mechanisms in the activation of nuclear factor-κB. Free Radic Biol Med 28: 1317-1327. (Pubitemid 30621476)
18. Jones PF, Jakubowicz T, Pitossi FJ, Maurer F, Hemmings BA, (1991). Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc Natl Acad Sci USA 88: 4171-4175. (Pubitemid 21914501)
19. Kane LP, Shapiro VS, Stokoe D, Weiss A, (1999). Induction of NF-κB by the Akt/PKB kinase. Curr Biol 9: 601-604.
20. Karin M, Ben-Neriah Y, (2001). Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18: 621-663. (Pubitemid 30365393)
21. Lee SJ, Lim KT, (2008). Inhibitory effect of 30 kDa phytoglycoprotein on expression of TNF-α and COX-2 via activation of PKC-α and ERK 1/2 in LPS-stimulated RAW 264.7 cells. Mol Cell Biochem 317: 151-159.
22. Lee YM, Seon MR, Cho HJ, Kin J, Park HJY, (2009). Benzyl isothiocyanate exhibits anti-inflammatory effects in murine macrophages and in mouse skin. J Mol Med 87: 1251-1261.
23. Li Q, Verma IM, (2001). NF-κB regulation in the immune system. Nat Rev Immunol 2: 725-734.
24. Maus UA, Waelsch K, Kuziel WA, Delbeck T, Mack M, Blackwell TS, et al. (2003). Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J Immunol 170: 3273-3278. (Pubitemid 36302205)
25. Meng F, Liu L, Chin PC, D'Mello SR, (2002). Akt is a downstream target of NF-κB. J Biol Chem 277: 29674-29680.
26. Meng F, Liu L, Chin PC, D'Mello SR, (2010). Akt is a downstream target of NF-κB. J Biol Chem 277: 29674-29680.
27. Mukherjee DG, Dey CD, (1996). Clinical trial on Brahmi. J Exp Med Sci 10: 5-9.
28. x, iNOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121: 2357-2363. (Pubitemid 350022403)
29. Piwien-Pilipuk G, Van Mater D, Ross SE, MacDougald OA, Schwartz J, (2001). Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein-β by modulating Akt and glycogen synthase kinase-3. J Biol Chem 276: 19664-19671.
30. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. (1999). Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signaling complex. Oncogene 18: 6013-6020. (Pubitemid 29535013)
31. Reddy ST, Wadleigh DJ, Herschman HR, (2000). Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem 275: 3107-3113. (Pubitemid 30083007)
32. Ren W, Qin L, Xu V, Cheng N, (2010). Inhibition of betulinic acid to growth and angiogenesis of human colorectal cancer cell in nude mice. Chinese-German J Clin Oncol 9: 153-157.
33. Rohini G, Devi CS, (2008). Bacopa monniera extract induces apoptosis in murine sarcoma cells (S-180). Phytother Res 22: 1595-1598.
34. Sairam K, Rao CV, Babu MD, Goel RK, (2001). Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine 8: 423-430. (Pubitemid 34052596)
35. Santos M, Costa JF, Krettli AU, Zalis MG, Maia GL, Sette IM, et al. (2009). Anti-malarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice. Parasitol Res 105: 275-279.
36. Schachter M, (2003). COX-2 inhibitors and cardiovascular risk. Br J Cardiol 10: 288-292. (Pubitemid 37086746)
37. Sezler E, Thallinger C, Hoeller C, Oberkleiner P, Wachek V, Pehamberger H, et al. (2002). Betulinic acid induced Mcl-1 expression in human melanoma-mode of action and functional significance. Mol Med 8: 887-884.
38. Shacter E, Weitzman SA, (2002). Chronic inflammation and cancer. Oncology 16: 217-226.
39. Singh A, Singh SK, (2009). Reversible suppression of spermatogenesis and fertility without toxic effects. Contraception 79: 71-79.
40. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714. (Pubitemid 28144551)
41. Takada V, Aggarwal BB, (2003). Betulinic acid suppresses carcinogen-induced NF-κB activation through inhibition of IκBα kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 171: 3278-3286. (Pubitemid 37093555)
42. Tan Y, Yu R, Pezzuto JM, (2003). Betulinic acid induced programmed cell death in human melanoma cells involves mitogen activated protein kinase activation. Clin Cancer Res 9: 2866-2875. (Pubitemid 36842133)
43. Vijayan V, Helen A, (2007). Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice. Phytother Res 21: 378-381. (Pubitemid 46595985)
44. Viji V, Helen A, (2008). Inhibition of lipoxygenases and cyclooxygenase-2 enzymes by extracts isolated from Bacopa monniera (L.) Wettst. J Ethnopharmacol 118: 305-311.
45. Viji V, Shobha B, Kavitha SK, Ratheesh M, Kripa K, Helen A, (2010). Betulinic acid isolated from Bacopa monniera (L.) Wettst suppresses lipopolysaccharide stimulated interleukin-6 production through modulation of nuclear factor-κB in peripheral blood mononuclear cells. Int Immunopharmacol 10: 843-849.
46. Vohora D, Pal SN, Pillai KK, (2000). Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant. J Ethnopharmacol 71: 383-390. (Pubitemid 30642860)
47. Wang L, Shao J, Muhlenkamp P, Liu S, Klepcyk P, Ren J, et al. (2000). Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancerbinding protein-β. J Biol Chem 275: 14173-14181. (Pubitemid 30339694)
48. Wang Y, Chang J, Li YC, Li YS, Shyy JY, Chien S, (2004). Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiol Heart Circ Physiol 286: 685-692.
49. Watanabe K, Jinnouchi K, Yagi T, (2002). Immunoreactivity for myeloperoxidase in the vestibule after the injection of bacterial lipopolysaccharide into the middle ear. Auris Nasus Larynx 29: 241-245. (Pubitemid 34876998)
50. Yoon JJ, Lee YJ, Kim JS, Kang DG, Lee HS, (2010). Protective role of betulinic acid on TNF-α-induced cell adhesion molecules in vascular endothelial cells. Biochem Biophys Res Commun 391: 96-101.
51. Yun Y, Han S, Park E, Yim D, Lee S, Lee C, et al. (2003). Immunomodulatory activity of betulinic acid by producing pro-inflammatory cytokines and activation of macrophages. Archives Pharmacol Res 26: 1087-1095.
52. Zuchermann SH, Bendele AM, (1989). Regulation of serum tumor necrosis factor alpha in glucocorticoid sensitive and resistant rodent endotoxin shock models. Infect Immun 57: 3009-3013. (Pubitemid 19240067)